SCHEMBL2809328

SCHEMBL2809328

C#Cc1cc(Cl)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.50
TSHR P16473 2/20 0.50
HPGD P15428 5/20 0.46
ALOX15 P16050 4/20 0.46
ALDH1A1 P00352 3/20 0.46
ALOX12 P18054 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPK1 P28482 1/20 0.46
CYP3A4 P08684 4/20 0.45
HIF1A Q16665 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HSP90AA1 P07900 3/20 0.45
HTT P42858 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
HSPA5 P11021 2/20 0.45
SLC22A1 O15245 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9239585 0.81 HSD17B10 (0.54) HSD17B10TSHRHPGDALOX15ALDH1A1
SCHEMBL584161 0.77 HSD17B10 (0.50) HSD17B10TSHRHPGDALOX15ALDH1A1
SCHEMBL5163990 0.77 HSD17B10 (0.50) HSD17B10TSHRHPGDALOX15ALDH1A1
SCHEMBL29771448 0.76 ESR1 (0.44) HSD17B10ALOX15ALDH1A1CYP3A4HTT
SCHEMBL358267 0.76 ESR1 (0.44) HSD17B10ALOX15ALDH1A1CYP3A4HTT
SCHEMBL11420886 0.76 APP (0.48) HSD17B10HPGDALOX15ALDH1A1ALOX12
SCHEMBL718733 0.76 TP53 (0.48) HSD17B10TSHRALOX15ALDH1A1SMN1; SMN2
SCHEMBL1544963 0.74 PTGDR2 (0.36) HSD17B10TSHRALOX15ALDH1A1SMN1; SMN2
SCHEMBL13646420 0.73 CA1 (0.46) HSD17B10TSHRHPGDALOX15ALDH1A1
SCHEMBL1121945 0.73 TRPA1 (0.52) HSD17B10HPGDALOX15ALDH1A1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024222614-A1 HETEROCYCLIC GSPT1 DEGRADATION AGENT 北京诺诚健华医药科技有限公司 2024-10-31 WO disclosed
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 US disclosed
CN-101868444-A Acetylenic compound, salt thereof, condensate thereof, and composition thereof FUJIFILM CORP 2010-10-20 CN disclosed
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
CN-101808982-A Acetylene compound FUJIFILM CORP 2010-08-18 CN disclosed
EP-2202220-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF Fujifilm Corporation (JP) 2010-06-30 EP disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B HSD17B10 534/4885TSHR 3644/4885HPGD 1111/4885
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 HSD17B10 272/4885TSHR 4692/4885HPGD 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.